The company has announced the availability of its next-generation electrosurgical generator. Credit: PRNewswire / Olympus Corporation.

Medical technology company Olympus has introduced its new ESG-410 electrosurgical generator to treat enlarged prostate and bladder cancer.

The electrosurgical generator offers a range of band electrodes, vaporisation buttons, needles and resection loops, which help in efficiently treating non-muscle-invasive bladder cancer and benign prostatic hyperplasia or enlarged prostate.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The ESG-410 features larger capacitors compared to the company’s previous model, the ESG-400, enabling improved plasma stability during ignition.

The generator can offer rapid ignition and enhanced plasma stability while avoiding tissue contact with large, medium and band loops and oval buttons, compared to the previous version.

Furthermore, it also has a larger 8.4″ LCD touch screen than the ESG-400 and wireless foot pedals. Olympus is also offering wired options for the generator.

See Also:

Using its accessories and ancillary equipment, the generator will support cutting and coagulating tissue in open, laparoscopic and endoscopic surgery. It must be used by a qualified physician in a suitable medical environment.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

According to Olympus, incorrect use of the electrosurgical generator or incompatible use of equipment may result in the generation of excessive or incorrect high-frequency energy, potentially leading to thermal or other injuries for both the patient and the operator.

In December last year, Olympus reached a definitive agreement to acquire UK-based cloud-AI endoscopy start-up Odin Vision.

Odin Vision offers a portfolio of computer-aided diagnostic solutions, as well as a deep innovation pipeline of cloud-enabled applications.